1223-CAR T细胞治疗复发性胶母细胞瘤的内源免疫演变 episode artwork

EPISODE · Jul 3, 2026 · 13 MIN

1223-CAR T细胞治疗复发性胶母细胞瘤的内源免疫演变

from 聊聊Sci

这份文章探讨了在复发性胶质母细胞瘤患者中,通过脑室内注射 CAR T 细胞疗法后的免疫反应机制。研究人员利用单细胞 RNA 测序和光谱流式细胞术等先进技术,详细分析了治疗后患者脑脊液及肿瘤组织内免疫环境的演变。研究重点揭示了宿主自身内源性免疫系统在治疗过程中的关键作用,观察到治疗引发了显著的免疫细胞表型转化。实验数据进一步表明,恶性细胞在压力下会发生间质化转变并建立代谢防御屏障,从而产生治疗耐药性。该研究不仅提供了详尽的分子图谱,还为优化针对脑部恶性肿瘤的细胞免疫疗法提供了理论依据。References:Freeburg N F, Chafamo D, Gopikrishna G K, et al. The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM[J]. Cell, 2026.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Jul 3, 2026

Embed this episode

Ready to play

1223-CAR T细胞治疗复发性胶母细胞瘤的内源免疫演变

0:00 13:52

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 13 minutes long.

When was this 聊聊Sci episode published?

This episode was published on July 3, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!